United Therapeutics Corporation Announces Registration
18.06.1999, 20:06
Statement Declared Effective by SEC Silver Spring, Md. (PROTEXT) - Martine Rothblatt, Chairman andCEO of United Therapeutics Corporation (Nasdaq: UTHR), announcedtoday that the registration statement for its initial publicoffering has been declared effective by the Securities andExchange Commission. United Therapeutics has registered for saleto the public 4,500,000 shares of its Common Stock. The price tothe public will be $12.00 per share. United Therapeutics expectstrading in its Common Stock to begin today on the Nasdaq NationalMarket. Deutsche Banc Alex. Brown is acting as lead manager of theunderwriting. A.G. Edwards & Sons, Inc. and Vector SecuritiesInternational, Inc. are acting as co-managers of the offering. Awritten prospectus may be obtained from Deutsche Banc Alex.Brown's Prospectus Department at One South Street, Baltimore,Maryland (410-727-1700). United Therapeutics develops pharmaceuticals to treat vasculardiseases, including pulmonary hypertension and peripheralvascular disease, as well as selected other chronic conditions.ots Original Text Service: United Therapeutics CorporationInternet: http://www.newsaktuell.de Contact: Deutsche BancAlex. Brown's Prospectus Department (USA) 410-727-1700, forUnited Therapeutics Corporation Web site:http://www.unitedtherapeutics.com
Subscribers please note that material bearing the slug"PROTEXT" is not part of CTK's news service and is not to bepublished under the "CTK" slug. Protext is a commercial serviceproviding distribution of press releases from clients, who areidentified in the text of Protext reports and who bear fullresponsibility for their contents.
PROTEXT